Citations

Mayo Clinic

Showing 10 of 108602 citations.

PET/MRI Applications in Pediatric Epilepsy
Pedersen, Christian , Aboian, Mariam , Franceschi, Ana M. , Messina, Steven A. , Franceschi, Ana M , Aboian, Mariam S , Daldrup-Link, Heike

World Journal of Nuclear Medicine | April 28, 2023 | Volume: 22 | Issue: 02 | Pages: 078-086

10.1055/s-0043-1764303 | PMID 37223623 Get It

Abstract Epilepsy neuroimaging assessment requires exceptional anatomic detail, physiologic and metabolic information. Magnetic resonance (MR) protocols are often time-consuming necessitating sedation and positron emission tomography (PET)/computed tomography (CT) comes with a significant radiation dose. Hybrid PET/MRI protocols allow for exquisite assessment of brain anatomy and structural abnormalities, in addition to metabolic information in a single, convenient imaging session, which limits radiation dose, sedation time, and sedation events. Brain PET/MRI has proven especially useful for accurate localization of epileptogenic zones in pediatric seizure cases, providing critical additional information and guiding surgical decision making in medically refractory cases. Accurate localization of seizure focus is necessary to limit the extent of the surgical resection, preserve healthy brain tissue, and achieve seizure control. This review provides a systematic overview with illustrative examples demonstrating the applications and diagnostic utility of PET/MRI in pediatric epilepsy.
Age and Sex Distributions of MOG-IgG and AQP4-IgG Positive Sera from a Large Neuroimmunology Laboratory Database (P2-5.028)
Vorasoot, Nisa , Kunchok, Amy , Edmond, Matthew C., McCombe, Jennifer A. , Redenbaugh, Vyanka , Tisavipat, Nanthaya , Abdulrahman, Yahya, Chen, John , Irani, Sarosh R. , Irani, Sarosh R , Pittock, Sean J , Vorasoot, Nisa , Tisavipat, Nanthaya , Cacciaguerra, Laura , Thakolwiboon, Smathorn , Pittock, Sean J. , Flanagan, Eoin P.

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000204098 Get It

Clinical Characteristics of Early-Onset Parkinson Disease in Mayo Clinic Population (P6-11.004)
Ghoniem, Khaled , Jacobson, Jessie, Turcano, Pierpaolo , Camerucci, Emanuele, Bower, James, Savica, Rodolfo , Mullan, Aidan F. , Camerucci, Emanuele , Stang, Cole

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000202625 Get It

Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results
Bhojani, Naeem , Bidair, Mo, Kramolowsky, Eugene V., Desai, Mihir, Doumanian, Leo, Zorn, Kevin C. , Elterman, Dean , Kaufman, Ronald P., Eure, Gregg , Badlani, Gopal , Plante, Mark , Uchio, Edward , Gin, Greg , Paterson, Ryan, So, Alan , Roehrborn, Claus, Motola, Jay , Kaplan, Steven, Humphreys, Mitch, Bidair, Mohamed

Journal of Urology | April 28, 2023 | Volume: 210 | Issue: 1 | Pages: 143-153

10.1097/ju.0000000000003483 | PMID 37115632 Get It

Digital Health: A New Frontier
Barracca, Antonio, Ledda, Stefano, Mancosu, Gianmaria, Quintaliani, Giuseppe, Kashani, Kianoush , Kashani, Kianoush B , Ledda, Stefano, Mancosu, Gianmaria, Pintore, Giovanni , Ronco, Claudio

Journal of Translational Critical Care Medicine | April 28, 2023 | Volume: 5 | Issue: 2 | Pages: No page available

10.1097/jtccm-d-22-00018 Get It

ABSTRACT The Food and Drug Administration defines digital health (DH) as “a convergence of people, information, technology, and connectivity to improve health care and health outcomes”. Information and communication technologies are categorized under the DH umbrella. While still in their infancy, these technologies have great potential to revolutionize the clinical approaches to bedside management and overall health care. Over the past few decades, there has been a substantial improvement in the technology in smart wearable devices that enabled them to enhance their abilities to collect patient-related data, including physiological and behavioral information in the Internet of things. This has resulted in implementing several controlled clinical trials that have confirmed their validity and safety. These digital diagnostics have led to the expansion of digital therapies and specialized software (for example, apps) capable of effectively and measurably guiding patients’ progress toward improving their clinical condition. These technologies are clinically validated treatments for many diseases with particular effectiveness in pathological conditions related to behavior and psychological factors. In this review paper, we describe the outlines of some of the recent progress made in this field.
Technical note: Delivery benefit and dosimetric implication of synchrotron‐based proton pencil beam scanning using continuous scanning mode
Beltran, Chris , Liu, Chunbo , Shen, Jiajian , Shen, Jiajian , Beltran, Chris J , Liang, Xiaoying , Li, Heng , Furutani, Keith M.

Medical Physics | April 28, 2023 | Volume: 50 | Issue: 8 | Pages: 5252-5261

10.1002/mp.16434 | PMID 37115647 Get It

AbstractBackgroundDiscrete spot scanning (DSS) is the commonly used method for proton pencil beam scanning (PBS). There is lack of data on the dose‐driven continuous scanning (DDCS).PurposeTo investigate delivery benefits and dosimetric implications of DDCS versus DSS for PBS systems.MethodsThe irradiation duty factor, beam delivery time (BDT), and dose deviation were simulated for eight treatment plans in prostate, head and neck, liver, and lung, with both conventional fractionation and hypofractionation schemes. DDCS results were compared with those of DSS.ResultsThe DDCS irradiation duty factor (range, 11%–41%) was appreciably improved compared to DSS delivery (range, 4%–14%), within which, hypofractionation schemes had greater improvement than conventional fractionation. With decreasing stop ratio constraints, the DDCS BDT reduction was greater, but dose deviation also increased. With stop ratio constraints of 2, 1, 0.5, and 0, DDCS BDT reduction reached to 6%, 10%, 12%, and 15%, respectively, and dose deviation reached to 0.6%, 1.7%, 3.0%, and 5.2% root mean square error in PTV DVH, respectively. The 3%/2‐mm gamma passing rate was greater than 99% with stop ratio constraints of 2 and 1, and greater than 95% with a stop ratio of 0.5. When the stop ratio constraint was removed, five of the eight treatment plans had a 3%/2‐mm gamma passing rate greater than 95%, and the other three plans had a 3%/2‐mm gamma passing rate between 90% and 95%.ConclusionsThe irradiation duty factor was considerably improved with DDCS. Smaller stop ratio constraints led to shorter BDTs, but with the cost of larger dose deviations. Our finding suggested that a stop ratio of 1 constraint seems to yield acceptable DDCS dose deviation.
Lipid Nanoparticle Delivery of Small Proteins for Potent In Vivo RAS Inhibition
Haley, Rebecca M. , Chan, Alexander, Billingsley, Margaret M. , Gong, Ningqiang , Kim, Emily H. , Wang, Hejia , Yin, Dingzi, Wangensteen, Kirk J. , Tsourkas, Andrew , Tsourkas, Andrew , Mitchell, Michael J , Wangensteen, Kirk J , Chan, Alexander, Padilla, Marshall Scott , Mitchell, Michael J.

ACS Applied Materials & Interfaces | April 28, 2023 | Volume: 15 | Issue: 18 | Pages: 21877-21892

10.1021/acsami.3c01501 | PMID 37115558 Get It

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
Cabrera-Serrano, Antonio José , Sánchez‐Maldonado, José Manuel , Macauda, Angelica , García-Martín, Paloma, Benavente, Yolanda , Landi, Stefano , Clay‐Gilmour, Alyssa , Niazi, Yasmeen , Espinet, Blanca , Rodríguez‐Sevilla, Juan José , Pérez, Eva María, Maffei, Rossana , Blanco, Gonzalo , Giaccherini, Matteo , Marasca, Roberto , López‐Nevot, Miguel Ángel , Thomsen, Hauke , Gámez, Irene, Campa, Daniele , Moreno, Vı́ctor , Sanjosé, Sílvia de , Marcos‐Gragera, Rafael , García‐Álvarez, María , Dierssen‐Sotos, Trinidad , Jerez, Andrés , Butrym, Aleksandra , Hemminki, Kari , Li, Yang , Berndt, Sonja I. , Casabonne, Delphine , Alcoceba, Miguel , Puiggros, Anna , Netea, Mihai G. , Försti, Asta , Canzian, Federico , Sáinz, Juan , Benavente, Yolanda , Landi, Stefano , Espinet, Blanca , Rodríguez-Sevilla, Juan José , Maffei, Rossana , Blanco, Gonzalo , Giaccherini, Matteo , Marasca, Roberto , López-Nevot, Miguel Ángel , Thomsen, Hauke , Moreno, Victor , Marcos-Gragera, Rafael , Dierssen-Sotos, Trinidad , Jerez, Andrés , Butrym, Aleksandra , Hemminki, Kari , Li, Yang , Alcoceba, Miguel , Puiggros, Anna , Försti, Asta , Canzian, Federico , Sainz, Juan , Horst, Rob ter , García-Martín, Paloma, Cerhan, James R. , Chen-Liang, Tzu-Hua , Norman, Aaron D. , Luppi, Mario , Slager, Susan L. , Netea, M. G.

International Journal of Molecular Sciences | April 28, 2023 | Volume: 24 | Issue: 9 | Pages: 8005

10.3390/ijms24098005 | PMID 37175717 Get It

Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. Here, we evaluated whether 41 GWAS-identified risk variants for CLL could influence overall survival (OS) and disease progression, defined as time to first treatment (TTFT) in a cohort of 1039 CLL cases ascertained through the CRuCIAL consortium. Although this is the largest study assessing the effect of GWAS-identified susceptibility variants for CLL on OS, we only found a weak association of ten single nucleotide polymorphisms (SNPs) with OS (p < 0.05) that did not remain significant after correction for multiple testing. In line with these results, polygenic risk scores (PRSs) built with these SNPs in the CRuCIAL cohort showed a modest association with OS and a low capacity to predict patient survival, with an area under the receiver operating characteristic curve (AUROC) of 0.57. Similarly, seven SNPs were associated with TTFT (p < 0.05); however, these did not reach the multiple testing significance threshold, and the meta-analysis with previous published data did not confirm any of the associations. As expected, PRSs built with these SNPs showed reduced accuracy in prediction of disease progression (AUROC = 0.62). These results suggest that susceptibility variants for CLL do not impact overall survival and disease progression in CLL patients.
Short bowel syndrome: Complications and management
Bering, Jamie , DiBaise, John K.

Nutrition in Clinical Practice | April 28, 2023 | Volume: 38 | Issue: S1 | Pages: No page available

10.1002/ncp.10978 | PMID 37115034 Get It

AbstractShort bowel syndrome (SBS) occurs when a patient loses bowel length or function significantly enough to cause malabsorption, oftentimes requiring lifelong parenteral support. In adults, this occurs most commonly in the setting of massive intestinal resection, whereas congenital anomalies and necrotizing enterocolitis predominate in children. Many patients with SBS develop long‐term clinical complications over time related to their altered intestinal anatomy and physiology or to various treatment interventions such as parenteral nutrition and the central venous catheter through which it is administered. Identifying, preventing, and treating these complications can be challenging. This review will focus on the diagnosis, treatment, and prevention of several complications that can occur in this patient population, including diarrhea, fluid and electrolyte imbalance, vitamin and trace element derangements, metabolic bone disease, biliary disorders, small intestinal bacterial overgrowth, d‐lactic acidosis, and complications of central venous catheters.
Short bowel syndrome: Recognizing unmet needs
DiBaise, John K.

Nutrition in Clinical Practice | April 28, 2023 | Volume: 38 | Issue: S1 | Pages: No page available

10.1002/ncp.10948 | PMID 37115035 Get It